FIRST TRUST AMEX BIOTECH INDEX FUND
FIRST TRUST AMEX BIOTECH INDEX FUND
Fund · US33733E2037 · FBT (ARCX)
Overview
165,46 USD
-0,08 % -0,13 USD
NYSE (XNYS) · Current prices and charts at MoneyPeak
10.06.2025 19:59

Current Prices from FIRST TRUST AMEX BIOTECH INDEX FUND

ExchangeTickerCurrencyLast TradePriceDaily Change
XNYS: NYSE
NYSE
FBT
USD
10.06.2025 19:59
165,46 USD
165,60 USD
-0,08 %

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
0,00 % 1,34 % 7,89 % -3,94 % -4,91 % 8,24 % -0,30 %
Asset Allocation
AssetPercentage %
Stock US91,89 %
Stock non-US8,04 %
Cash0,07 %
NotClassified0,00 %
Other0,00 %
Bond0,00 %
Largest Positions
SymbolISINNamePercentage %
BNTXBioNTech SE 4,77 %
MRNAModerna Inc 4,36 %
ALKSAlkermes plc 4,18 %
REGNRegeneron Pharmaceuticals Inc 3,73 %
QGENQIAGEN N.V 3,71 %
ALNYAlnylam Pharmaceuticals Inc 3,69 %
SRPTSarepta Therapeutics Inc 3,67 %
CRLCharles River Laboratories International Inc 3,64 %
UTHRUnited Therapeutics Corporation 3,62 %
SGENSeagen Inc 3,59 %
Region Distribution
RegionPercentage %
North America91,95 %
Europe Developed8,05 %
Africa/Middle East0,00 %
Asia Developed0,00 %
Asia Emerging0,00 %
Australasia0,00 %
Europe Emerging0,00 %
Japan0,00 %
Latin America0,00 %
United Kingdom0,00 %
Sector Distribution
SectorPercentage %
Gesundheitswesen100,00 %
Grundstoffe0,00 %
Verbrauchsgüter0,00 %
Finanzdienstleistungen0,00 %
Immobilien0,00 %
Telekommunikation0,00 %
Energie0,00 %
Industrieunternehmen0,00 %
Technologie0,00 %
Basiskonsumgüter0,00 %

Company Profile for FIRST TRUST AMEX BIOTECH INDEX FUND Fund

The fund will normally invest at least 90% of its net assets (including investment borrowings) in the common stocks and depositary receipts that comprise the index. The index is an equal-dollar weighted index designed to measure the performance of a cross section of small, mid and large capitalization companies in the biotechnology industry that are primarily involved in the use of biological processes to develop products or provide services.
Fund Master Data
Issuer First Trust
Asset Class ETF
Name First Trust NYSE Arca Biotechnology Index Fund
Fund Currency USD
Category Health
Payout NA
fund.
Morningstar Rating 2
Fund Key Figures
Fund Size 1,96 M EUR
Investment Strategy
The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of an equity index called the NYSE Arca Biotechnology IndexSM. The fund will normally invest at least 90% of its net assets (including investment borrowings) in the common stocks and depositary receipts that comprise the index. The index is an equal-dollar weighted index designed to measure the performance of a cross section of small, mid and large capitalization companies in the biotechnology industry that are primarily involved in the use of biological processes to develop products or provide services.

Company Data

Name FIRST TRUST AMEX BIOTECH INDEX FUND
Company First Trust NYSE Arca Biotechnology Index Fund
Symbol FBT
Primary Exchange ARCX NYSE
ISIN US33733E2037
Asset Class Fund
Sector Financial Services
Industry Asset Management
Market Capitalization 3 Mrd.
Country United States of America
Currency USD
Employees -
IPO Date 2006-06-23
Dividends from 'FIRST TRUST AMEX BIOTECH INDEX FUND'
Ex-Date Dividend per Share
13.12.2024 1,17 USD
30.12.2021 2,21 USD
23.09.2015 0,02 USD
24.06.2015 0,07 USD
25.03.2015 0,05 USD
23.12.2014 0,05 USD
23.06.2008 0,27 USD

Ticker Symbols

Name Symbol
NYSE FBT

More Shares

Investors who FIRST TRUST AMEX BIOTECH INDEX FUND hold also have the following shares in their portfolio:
UNITEDHEALTH GRP 16/27
UNITEDHEALTH GRP 16/27 Bond
WESTPAC SEC.NZ 21/26 MTN
WESTPAC SEC.NZ 21/26 MTN Bond
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025